These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9256890)

  • 21. Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.
    Boiardi A; Silvani A; Pozzi A; Fariselli L; Broggi G; Salmaggi A
    J Neurooncol; 1999 Jan; 41(2):151-7. PubMed ID: 10222435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma.
    Chang SM; Barker FG; Huhn SL; Nicholas MK; Page M; Rabbitt J; Prados MD
    J Neurooncol; 1998 Apr; 37(2):169-76. PubMed ID: 9524096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
    Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
    Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F; Prados M; Russell C; Weissman D; Evans R; Cook P; Burton G; Eisenberg PD; Valenzuela R; Verkh L
    J Neurooncol; 1997 Mar; 32(1):45-55. PubMed ID: 9049862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.
    Hassenbusch SJ; Nardone EM; Levin VA; Leeds N; Pietronigro D
    Neoplasia; 2003; 5(1):9-16. PubMed ID: 12659665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous BCNU and AZQ in patients with recurrent malignant gliomas.
    Yung WK; Harris MI; Bruner JM; Feun LG
    J Neurooncol; 1989 Sep; 7(3):237-40. PubMed ID: 2795118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L; Grossman SA; Piantadosi S; Zeltzman M; Wharam M
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):535-43. PubMed ID: 10348282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon alpha-2a and external beam radiotherapy in the initial management of patients with glioma: a pilot study of the National Biotherapy Study Group.
    Dillman RO; Wiemann M; Oldham RK; Soori G; Bury M; Hafer R; Church C; DePriest C
    Cancer Biother; 1995; 10(4):265-71. PubMed ID: 8590891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
    Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study.
    Lunardi P; Osman Farah J; Mastronardi L; Puzzilli F; Lo Bianco FM
    Acta Neurochir (Wien); 1996; 138(2):215-20. PubMed ID: 8686548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma.
    Morton RF; Creagan ET; Schaid DJ; Kardinal CG; McCormack GW; McHale MS; Wiesenfeld M
    Am J Clin Oncol; 1991 Apr; 14(2):152-5. PubMed ID: 2028922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
    Mack F; Schäfer N; Kebir S; Stuplich M; Schaub C; Niessen M; Scheffler B; Herrlinger U; Glas M
    Oncology; 2014; 86(5-6):369-72. PubMed ID: 24942787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
    Boiardi A; Eoli M; Pozzi A; Salmaggi A; Broggi G; Silvani A
    Ital J Neurol Sci; 1999 Feb; 20(1):43-8. PubMed ID: 10933484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.